Apalutamide
Back to searchMolecule Structure
Scientific Name
Apalutamide
Description of the Drug
Apalutamide is an androgen receptor inhibitor used to treat non metastatic, castration resistant prostate cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11901
http://www.drugbank.ca/drugs/DB11901
Brand Name(s)
Erleada
Company Owner(s)
Janssen Biotech Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Androgen Receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1871 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL909297 | |
| Human Metabolome Database | HMDB0248608 | |
| DrugBank | DB11901 | |
| PubChem: Thomson Pharma | 50127665 | |
| PubChem | 24872560 | |
| LINCS | LSM-45475 | |
| Nikkaji | J3.239.948G | |
| BindingDB | 50094975 | |
| EPA CompTox Dashboard | DTXSID40241899 | |
| DrugCentral | 5278 | |
| ChemicalBook | CB92593622 | |
| Guide to Pharmacology | 9043 | |
| rxnorm | APALUTAMIDE | ERLEADA |
| ZINC | ZINC000043174901 |
